Private Equity

The Open Your Eyes to Private Equity 2019 meeting hosted a panel of physicians who have chosen a private equity transaction and those who have not to discuss their decision-making process.

In the fast-paced environment of private equity, there are terms every physician should know. Here is a quick-reference guide to those terms and their definitions, compiled with insight from Candace S. Simerson, FASOA, COE, CMPE, president of iCandy Consulting LLC, and Shareef Mahdavi, president of SM2 Strategic.

As health care faces continued reform, an aging population and an overall labor shortage, ophthalmology is uniquely positioned to be desirable to investors in the private equity realm, bringing questions and challenges with the opportunity.

MAUI, HAWAII — In a discussion hosted by the Women’s Dermatologic Society, panelists aligned with private equity-backed groups focused on whether independent dermatology practices can survive given the impact of private equity, burnout and diminishing revenue.

NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, Shareef Mahdavi, president of SM2 Strategic, discusses the importance of weighing the benefits and drawbacks of a private equity partnership.

NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, moderator John B. Pinto discusses the inaugural event, featuring “a whole arc of material, from basic to intermediate to advanced” presented in discussions on how ophthalmologists are affected through private equity partnerships.

NEW YORK — Knowing his audience consisted of ophthalmologists who are evaluating if private equity is right for them, trader and TV personality Guy Adami shared his philosophy for business and thoughts on current market forces.

NEW YORK — Richard L. Lindstrom, MD, discusses how private equity investments in ophthalmology could be beneficial to practice owners at the Open Your Eyes to Private Equity meeting preceding OSN New York 2019.

NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, Jim Mazzo, global president of ophthalmic devices at Carl Zeiss Meditec, discusses how the symposium is helpful to those interested in private equity investment.

I’m heading East to participate in the Healio event “Open Your Eyes to Private Equity” as a panelist tomorrow afternoon just ahead of the OSN New York meeting.